AbbVie 2013 Annual Report Download - page 114

Download and view the complete annual report

Please find page 114 of the 2013 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 176

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176

Exhibit
Number Exhibit Description
10.24 *Form of AbbVie Inc. Non-Employee Director Non-Qualified Stock Option Agreement
(incorporated by reference to Exhibit 10.3 of the Company’s Quarterly Report on Form 10-Q
for the quarterly period ended March 31, 2013).**
10.25 *Form of AbbVie Inc. Performance Restricted Stock Agreement (CEO/Chairman)
(incorporated by reference to Exhibit 10.4 of the Company’s Quarterly Report on Form 10-Q
for the quarterly period ended March 31, 2013).**
10.26 *Form of AbbVie Inc. Performance Restricted Stock Agreement (Annual) (incorporated by
reference to Exhibit 10.5 of the Company’s Quarterly Report on Form 10-Q for the quarterly
period ended March 31, 2013).**
10.27 *Form of AbbVie Inc. Performance Restricted Stock Agreement (Interim) (incorporated by
reference to Exhibit 10.6 of the Company’s Quarterly Report on Form 10-Q for the quarterly
period ended March 31, 2013).**
10.28 *Form of AbbVie Inc. Non-Qualified Stock Option Agreement (incorporated by reference to
Exhibit 10.7 of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended
March 31, 2013).**
10.29 *Form of AbbVie Inc. Non-Qualified Replacement Stock Option Agreement (incorporated by
reference to Exhibit 10.8 of the Company’s Quarterly Report on Form 10-Q for the quarterly
period ended March 31, 2013).**
12 Computation of Ratio of Earnings to Fixed Charges
21 Subsidiaries of AbbVie Inc.
23.1 Consent of Independent Registered Public Accounting Firm.
23.2 Consent of Independent Registered Public Accounting Firm.
31.1 Certification of Chief Executive Officer Required by Rule 13a-14(a) (17 CFR 240.13a-14(a)).
31.2 Certification of Chief Financial Officer Required by Rule 13a-14(a) (17 CFR 240.13a-14(a)).
32.1 Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101 The following financial statements and notes from the AbbVie Inc. Annual Report on
Form 10-K for the year ended December 31, 2013 filed on February 21, 2014, formatted in
XBRL: (i) Consolidated Statements of Earnings; (ii) Consolidated Statements of Cash Flows;
(iii) Consolidated Balance Sheets; and (iv) the notes to the consolidated financial statements.
The AbbVie Inc. 2014 Proxy Statement will be filed with the Securities and Exchange
Commission under separate cover on or about March 24, 2014.
* Incorporated herein by reference. Commission file number 001-35565.
** Denotes management contract or compensatory plan or arrangement required to be filed as an
exhibit hereto.
AbbVie will furnish copies of any of the above exhibits to a stockholder upon written request to
the Secretary, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064.
110